Prestige Consumer Healthcare Inc
PBH66.330USD
+0.780+1.19%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
3.19BMarket Cap
17.43P/E TTM
More Details of Prestige Consumer Healthcare Inc Company
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Prestige Consumer Healthcare Inc Info
Ticker SymbolPBH
Company namePrestige Consumer Healthcare Inc
IPO dateFeb 10, 2005
CEOLombardi (Ronald M)
Number of employees600
Security typeOrdinary Share
Fiscal year-endFeb 10
Address660 White Plains Rd.
CityTARRYTOWN
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code10591
Phone19145246800
Websitehttps://www.prestigebrands.com/
Ticker SymbolPBH
IPO dateFeb 10, 2005
CEOLombardi (Ronald M)
Company Executives of Prestige Consumer Healthcare Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-41249.00%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-30855.00%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
49.39K
-3000.00%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+3291.00%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
34.20K
-281.00%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+2094.00%
Mr. Adel Mekhail
Mr. Adel Mekhail
Executive Vice President - Marketing & Sales
Executive Vice President - Marketing & Sales
15.16K
-6794.00%
Ms. Dawn M. Zier
Ms. Dawn M. Zier
Independent Director
Independent Director
14.33K
+2094.00%
Dr. Celeste A. Clark, Ph.D.
Dr. Celeste A. Clark, Ph.D.
Independent Director
Independent Director
11.33K
+2094.00%
Mr. John F. Kelly
Mr. John F. Kelly
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-41249.00%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-30855.00%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
49.39K
-3000.00%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+3291.00%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
34.20K
-281.00%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+2094.00%
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
897.54M
78.89%
Rest of world
240.22M
21.11%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Jan 10
Updated: Sat, Jan 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.42%
The Vanguard Group, Inc.
11.36%
Ariel Investments, LLC
7.60%
Dimensional Fund Advisors, L.P.
5.48%
Kayne Anderson Rudnick Investment Management, LLC
4.68%
Other
56.46%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.42%
The Vanguard Group, Inc.
11.36%
Ariel Investments, LLC
7.60%
Dimensional Fund Advisors, L.P.
5.48%
Kayne Anderson Rudnick Investment Management, LLC
4.68%
Other
56.46%
Shareholder Types
Shareholders
Proportion
Investment Advisor
73.02%
Investment Advisor/Hedge Fund
30.37%
Research Firm
3.34%
Hedge Fund
2.52%
Pension Fund
1.38%
Individual Investor
1.34%
Sovereign Wealth Fund
1.16%
Family Office
0.70%
Bank and Trust
0.53%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
679
53.07M
110.37%
-424.78K
2025Q3
667
52.11M
108.37%
-2.03M
2025Q2
667
53.74M
109.15%
-2.00M
2025Q1
670
54.01M
109.68%
-1.79M
2024Q4
653
54.79M
110.61%
+365.71K
2024Q3
633
53.04M
107.02%
-1.71M
2024Q2
622
53.11M
106.92%
-2.21M
2024Q1
614
53.06M
106.87%
-2.26M
2023Q4
602
52.89M
106.58%
-3.51M
2023Q3
590
52.77M
106.53%
-2.81M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
6.83M
14.19%
-204.07K
-2.90%
Sep 30, 2025
The Vanguard Group, Inc.
5.48M
11.4%
-140.24K
-2.49%
Sep 30, 2025
Ariel Investments, LLC
3.59M
7.48%
+1.39M
+63.23%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.59M
5.39%
+119.46K
+4.83%
Sep 30, 2025
Kayne Anderson Rudnick Investment Management, LLC
2.21M
4.6%
+464.95K
+26.58%
Sep 30, 2025
State Street Investment Management (US)
1.96M
4.09%
-34.73K
-1.74%
Sep 30, 2025
Nomura Investment Management Business Trust
1.62M
3.37%
-346.31K
-17.60%
Sep 30, 2025
Allspring Global Investments, LLC
1.59M
3.31%
+70.38K
+4.62%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.44M
2.99%
+24.39K
+1.73%
Sep 30, 2025
Westwood Management Corp. (Texas)
1.14M
2.37%
+259.91K
+29.47%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco Pharmaceuticals ETF
2.44%
State Street SPDR S&P Pharmaceuticals ETF
2.43%
Schwab Ariel Opportunities ETF
2.28%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.05%
Congress SMid Growth ETF
1.94%
Invesco S&P SmallCap Health Care ETF
1.83%
iShares U.S. Pharmaceuticals ETF
1.1%
Brandes US Small-Mid Cap Value ETF
0.84%
Invesco S&P SmallCap Low Volatility ETF
0.71%
JPMorgan Active Small Cap Value ETF
0.68%
View more
Invesco Pharmaceuticals ETF
Proportion2.44%
State Street SPDR S&P Pharmaceuticals ETF
Proportion2.43%
Schwab Ariel Opportunities ETF
Proportion2.28%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion2.05%
Congress SMid Growth ETF
Proportion1.94%
Invesco S&P SmallCap Health Care ETF
Proportion1.83%
iShares U.S. Pharmaceuticals ETF
Proportion1.1%
Brandes US Small-Mid Cap Value ETF
Proportion0.84%
Invesco S&P SmallCap Low Volatility ETF
Proportion0.71%
JPMorgan Active Small Cap Value ETF
Proportion0.68%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
